Biomarker Guided Chemotherapy and Immunotherapy Response in Asian Triple-Negative Breast Cancer: A Systematic Review
Abstract
This project contains the PRISMA checklist, flow diagram, search strategy, and supporting data for a systematic review evaluating biomarker-guided chemotherapy and immunotherapy response in Asian triple-negative breast cancer (TNBC). The study follows PRISMA 2020 guidelines and includes qualitative synthesis.
Publication details
- Journal / source
- Open Science Framework
- Publication date
- 1 January 2026